Latest filing published 09 Sept 2024 for Fusion Antibodies plc, €3,677.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +392.3%Entry £0.03 · Close at T+365 £0.16
- -59.4%Entry £0.09 · Close at T+365 £0.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Richard Buick: trading record in brief
Richard Buick discloses dealings in Fusion Antibodies plc to RNS (LSE). Over a trading history stretching from 3 February 2020 to 9 September 2024, the count stands at 4 filings.
Market trades split into 2 purchases (€9,442) and 2 sales (€20k). On balance, insiders were net sellers of €10k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2024 to date brings 1 purchase and no sales.
The record was last updated on 9 September 2024 with an open-market purchase (€3,677) in Fusion Antibodies plc. Half of the filings or more reach the RNS (LSE) feed on the day of the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Richard Buick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 94,825 shares@ £0.032838.9% of flowXLON, London Stock ExchangeISIN GB00BDQZGK16RNS:5341314Canonical exit: 8 Dec 2024 (T+90)
- 68,750 shares@ £0.07261.1% of flowXLON, London Stock ExchangeISIN GB00BDQZGK16RNS:4799444Canonical exit: 7 Sept 2023 (T+90)
- 8,875 shares@ £0.01240.4% of flowLondon Stock Exchange, XLONISIN GB00BDQZGK16FCA-NSM:3854914
- 20,000 shares@ £0.8267.4% of flowLondon Stock Exchange, XLONISIN GB00BDQZGK16FCA-NSM:LSE20200203120143_3482003_20200331164938547_1086
4 of 4 declarations